Literature DB >> 2758246

Total or partial percutaneous renal ablation in the treatment of renovascular hypertension: radiological and clinical aspects.

V Iaccarino1, D Russo, R Niola, R Muto, A Testa, V E Andreucci, E Porta.   

Abstract

In 15 patients with renovascular hypertension, considered unsuitable for angioplasty or surgery, percutaneous renal ablation was performed by injection of ethanol into the renal vasculature. Partial or complete renal ablation was confirmed by follow-up intravenous pyelography or arteriography. Patients were followed-up for a mean of 24.8 months after therapy and blood pressure was improved in all patients with five being cured. This study shows that percutaneous renal ablation is a useful and successful method of therapy for renal hypertension, and that it should be considered in patients unsuitable for surgery or angioplasty.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758246     DOI: 10.1259/0007-1285-62-739-593

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

1.  Renal vascular lesions: diagnosis and endovascular management.

Authors:  A Rao Chimpiri; Balasubramani Natarajan
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

2.  Renal Sympathetic Denervation - A Review of Applications in Current Practice.

Authors:  Vikas Kapil; Ajay K Jain; Melvin D Lobo
Journal:  Interv Cardiol       Date:  2014-03

3.  Long-term control of hypertension and the predictive value of peripheral plasma renin activity after ablation of end stage kidneys with a new embolic agent.

Authors:  J H Peregrin; J Zabka; J Stríbrná; V Borůvka; V Martínek
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Nov-Dec       Impact factor: 2.740

4.  Management of renal arteriovenous malformations: A pictorial review.

Authors:  Adam Hatzidakis; Michele Rossi; Charalampos Mamoulakis; Elias Kehagias; Gianluigi Orgera; Miltiadis Krokidis; Apostolos Karantanas
Journal:  Insights Imaging       Date:  2014-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.